ALS Drug Development Summit

May 21-23
Boston, MA

As a specialty CRO in ALS research, PRC Clinical is proud to partner with the ALS Drug Development Summit and join in discussions on exploring meaningful endpoints and trial designs for patients with amyotrophic lateral sclerosis (ALS).

Over the last 15 years, our ALS experience has included regenerative medicine and pharmaceutical investigational products. We understand the unique challenges that come with rare and orphan-designated disease trials, from diagnosis difficulties to participant enrollment and patient stress. PRC has a wealth of experience in providing support for pre-study development before the launch of a study drug or biologic product and full clinical trial services from early through late-phase clinical trials. Fill out the form below to reserve a time to meet with PRC Clinical’s senior management and strategize on your programs.

View the Conference Website